CFTR Function Assessed in Airway Epithelial Cells
Corresponding Organization : Emory University
Other organizations : University of Alabama at Birmingham, University of Pittsburgh, USA Mitchell Cancer Institute, University of South Alabama, Southern Research Institute, National Institutes of Health, Center for Cancer Research, Pfizer (United States)
Variable analysis
- Genetic mutation (wild-type vs. F508del CFTR)
- Short-circuit current (Isc)
- Passage of CFBE41o- cells
- Coating of permeable supports with fibronectin
- Confluence of cell monolayers
- Bathing solution composition (Ringer's solution)
- Temperature (37°C)
- Oxygenation (95% O2, 5% CO2)
- Agonists (forskolin, genistein, ivacaftor)
- Inhibitor (CF inhibitor 172)
- Positive control: Addition of agonists (forskolin, genistein, ivacaftor) to stimulate CFTR activity
- Negative control: Addition of CF inhibitor 172 to block CFTR-dependent Isc
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!